Emergent BioSolutions
EBS
#8360
Rank
C$0.44 B
Marketcap
C$8.62
Share price
0.66%
Change (1 day)
-44.09%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): -C$0.14 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are C$0.74 Billion. In 2025 the company made an earning of C$0.20 Billion, an increase over its 2024 earnings that were of -C$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.14 Billion-167.73%
2025 C$0.20 B-297.64%
2024 -C$0.11 Billion-88.82%
2023 -C$0.91 Billion242.73%
2022 -C$0.27 Billion-153.8%
2021 C$0.49 B-20.43%
2020 C$0.61 B278.02%
2019 C$0.16 B27.11%
2018 C$0.12 B-27.12%
2017 C$0.17 B17.21%
2016 C$0.15 B0.45%
2015 C$0.15 B73.51%
2014 C$86.64 M41.36%
2013 C$61.29 M35.2%
2012 C$45.33 M0.4%
2011 C$45.15 M-56.46%
2010 C$0.10 B76.73%
2009 C$58.68 M32.94%
2008 C$44.14 M-5.62%
2007 C$46.77 M
2005 C$67.71 M269.89%
2004 C$18.3 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.76 B-7,362.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.86 B-8,186.23%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$10.11 B-7,623.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-C$16.55 Million-87.69%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
-C$15.75 Million-88.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.47 Billion 242.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.26 B-1,787.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel